You can still find attractive stocks despite all of the turbulence. Many stocks have been losers in 2025 amid the market chaos, but not Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B). Shares of Warren ...

U.S. stock futures point to a lower open as investors brace for one of the busiest weeks of earnings season. More than a ...

Pfizer announced that its experimental drug sasanlimab, when combined with BCG therapy, significantly improved event-free ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Reviewing PFE’s five-year history, the stock has experienced a balanced 50-50 distribution of positive and negative returns ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a ...

Pfizer has declared a quarterly dividend of $0.43 per share for Q2 2025, marking its 346th consecutive quarter of payouts.

Pfizer Inc. stock hits a 12-year low due to M&A missteps and high debt. Click here to find out why I rate PFE stock a Hold.

Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks ...

We recently published a list of 15 Recent Activist Investor Campaigns. In this article, we are going to take a look at where ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...